{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:04:15Z","timestamp":1792760655931,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07995"],"award-info":[{"award-number":["22K07995"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78462-8","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:36:14Z","timestamp":1731584174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Platelet activation through CD62P and the formation of platelet\u2013monocyte complexes are associated with the exacerbation of mucosal inflammation in patients with ulcerative colitis"],"prefix":"10.1038","volume":"14","author":[{"given":"Yasuki","family":"Sano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Honzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Ikeura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"78462_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre, C., Honap, S. & Peyrin-Biroulet, L. Ulcerative colitis. Lancet. 402, 571\u2013584. https:\/\/doi.org\/10.1016\/S0140-6736(23)00966-2 (2023).","journal-title":"Lancet"},{"key":"78462_CR2","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts, P. et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl. J. Med. 353, 2462\u20132476. https:\/\/doi.org\/10.1056\/NEJMoa050516 (2005).","journal-title":"N Engl. J. Med."},{"key":"78462_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands, B. E. et al. Ustekinumab as induction and maintenance therapy for Ulcerative Colitis. N Engl. J. Med. 381, 1201\u20131214. https:\/\/doi.org\/10.1056\/NEJMoa1900750 (2019).","journal-title":"N Engl. J. Med."},{"key":"78462_CR4","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1056\/NEJMoa2207940","volume":"388","author":"G D\u2019Haens","year":"2023","unstructured":"D\u2019Haens, G. et al. Mirikizumab as induction and maintenance therapy for Ulcerative Colitis. N Engl. J. Med. 388, 2444\u20132455. https:\/\/doi.org\/10.1056\/NEJMoa2207940 (2023).","journal-title":"N Engl. J. Med."},{"key":"78462_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","volume":"369","author":"BG Feagan","year":"2013","unstructured":"Feagan, B. G. et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl. J. Med. 369, 699\u2013710. https:\/\/doi.org\/10.1056\/NEJMoa1215734 (2013).","journal-title":"N Engl. J. Med."},{"key":"78462_CR6","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","volume":"123","author":"CN Morrell","year":"2014","unstructured":"Morrell, C. N., Aggrey, A. A., Chapman, L. M. & Modjeski, K. L. Emerging roles for platelets as immune and inflammatory cells. Blood. 123, 2759\u20132767. https:\/\/doi.org\/10.1182\/blood-2013-11-462432 (2014).","journal-title":"Blood"},{"key":"78462_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","volume":"149","author":"CN Harrison","year":"2010","unstructured":"Harrison, C. N. et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br. J. Haematol. 149, 352\u2013375. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08122.x (2010).","journal-title":"Br. J. Haematol."},{"key":"78462_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2174\/138161212799504731","volume":"18","author":"K Aksu","year":"2012","unstructured":"Aksu, K., Donmez, A. & Keser, G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr. Pharm. Des. 18, 1478\u20131493. https:\/\/doi.org\/10.2174\/138161212799504731 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"78462_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/00365521.1973.12096682","volume":"8","author":"I Talstad","year":"1973","unstructured":"Talstad, I., Rootwelt, K. & Gjone, E. Thrombocytosis in ulcerative colitis and Crohn\u2019s disease. Scand. J. Gastroenterol. 8, 135\u2013138 (1973).","journal-title":"Scand. J. Gastroenterol."},{"key":"78462_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrgastro.2014.202","volume":"12","author":"S Singh","year":"2015","unstructured":"Singh, S., Kullo, I. J., Pardi, D. S. & Loftus, E. V. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat. Rev. Gastroenterol. Hepatol. 12, 26\u201335. https:\/\/doi.org\/10.1038\/nrgastro.2014.202 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"78462_CR11","doi-asserted-by":"publisher","first-page":"e25595","DOI":"10.1371\/journal.pone.0025595","volume":"6","author":"G Passacquale","year":"2011","unstructured":"Passacquale, G. et al. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS One. 6, e25595. https:\/\/doi.org\/10.1371\/journal.pone.0025595 (2011).","journal-title":"PLoS One"},{"key":"78462_CR12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/hc3801.095588","volume":"104","author":"AD Michelson","year":"2001","unstructured":"Michelson, A. D., Barnard, M. R., Krueger, L. A., Valeri, C. R. & Furman, M. I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 104, 1533\u20131537. https:\/\/doi.org\/10.1161\/hc3801.095588 (2001).","journal-title":"Circulation"},{"key":"78462_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.thromres.2011.04.018","volume":"128","author":"JF Th\u00e9or\u00eat","year":"2011","unstructured":"Th\u00e9or\u00eat, J. F., Yacoub, D., Hachem, A., Gillis, M. A. & Merhi, Y. P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation. Thromb. Res. 128, 243\u2013250. https:\/\/doi.org\/10.1016\/j.thromres.2011.04.018 (2011).","journal-title":"Thromb. Res."},{"key":"78462_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/01.RES.0000074030.98009.FF","volume":"92","author":"JE Freedman","year":"2003","unstructured":"Freedman, J. E. CD40-CD40L and platelet function: beyond hemostasis. Circ. Res. 92, 944\u2013946. https:\/\/doi.org\/10.1161\/01.RES.0000074030.98009.FF (2003).","journal-title":"Circ. Res."},{"key":"78462_CR15","doi-asserted-by":"crossref","unstructured":"Azorsa, D. O., Hyman, J. A. & Hildreth, J. E. CD63\/Pltgp40: a platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491. Blood 78, 280\u2013284 (1991).","DOI":"10.1182\/blood.V78.2.280.bloodjournal782280"},{"key":"78462_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2141.1991.tb08010.x","volume":"79","author":"GP Anderson","year":"1991","unstructured":"Anderson, G. P., van de Winkel, J. G. & Anderson, C. L. Anti-GPIIb\/IIIa (CD41) monoclonal antibody-induced platelet activation requires fc receptor-dependent cell-cell interaction. Br. J. Haematol. 79, 75\u201383. https:\/\/doi.org\/10.1111\/j.1365-2141.1991.tb08010.x (1991).","journal-title":"Br. J. Haematol."},{"key":"78462_CR17","doi-asserted-by":"publisher","first-page":"17420","DOI":"10.1016\/S0021-9258(18)38177-8","volume":"265","author":"P Thiagarajan","year":"1990","unstructured":"Thiagarajan, P. & Tait, J. F. Binding of annexin V\/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J. Biol. Chem. 265, 17420\u201317423 (1990).","journal-title":"J. Biol. Chem."},{"key":"78462_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1182\/blood.V91.2.491","volume":"91","author":"B Kehrel","year":"1998","unstructured":"Kehrel, B. et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb\/IIIa, and Von Willebrand factor do not. Blood. 91, 491\u2013499 (1998).","journal-title":"Blood"},{"key":"78462_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jviromet.2012.02.005","volume":"181","author":"MV Singh","year":"2012","unstructured":"Singh, M. V., Davidson, D. C., Kiebala, M. & Maggirwar, S. B. Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. J. Virol. Methods. 181, 170\u2013176. https:\/\/doi.org\/10.1016\/j.jviromet.2012.02.005 (2012).","journal-title":"J. Virol. Methods"},{"key":"78462_CR20","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder, K. W., Tremaine, W. J. & Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl. J. Med. 317, 1625\u20131629. https:\/\/doi.org\/10.1056\/NEJM198712243172603 (1987).","journal-title":"N Engl. J. Med."},{"key":"78462_CR21","doi-asserted-by":"publisher","first-page":"154157","DOI":"10.1016\/j.cyto.2017.09.013","volume":"122","author":"C Bakogiannis","year":"2019","unstructured":"Bakogiannis, C., Sachse, M., Stamatelopoulos, K. & Stellos, K. Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine. 122, 154157. https:\/\/doi.org\/10.1016\/j.cyto.2017.09.013 (2019).","journal-title":"Cytokine"},{"key":"78462_CR22","doi-asserted-by":"publisher","first-page":"e0149775","DOI":"10.1371\/journal.pone.0149775","volume":"11","author":"X Wang","year":"2016","unstructured":"Wang, X., Luo, Y., Masci, P. P., Crawford, R. & Xiao, Y. Influence of Interleukin-1 Beta on platelet-poor plasma clot formation: a potential impact on Early Bone Healing. PLoS One. 11, e0149775. https:\/\/doi.org\/10.1371\/journal.pone.0149775 (2016).","journal-title":"PLoS One"},{"key":"78462_CR23","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science. 303, 1532\u20131535. https:\/\/doi.org\/10.1126\/science.1092385 (2004).","journal-title":"Science"},{"key":"78462_CR24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1160\/TH14-03-0281","volume":"112","author":"S Sadallah","year":"2014","unstructured":"Sadallah, S., Amicarella, F., Eken, C., Iezzi, G. & Schifferli, J. A. Ectosomes released by platelets induce differentiation of CD4\u2009+\u2009T cells into T regulatory cells. Thromb. Haemost. 112, 1219\u20131229. https:\/\/doi.org\/10.1160\/TH14-03-0281 (2014).","journal-title":"Thromb. Haemost"},{"key":"78462_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/art.42382","volume":"75","author":"H El Bannoudi","year":"2023","unstructured":"El Bannoudi, H. et al. Platelet LGALS3BP as a mediator of myeloid inflammation in systemic Lupus Erythematosus. Arthritis Rheumatol. 75, 711\u2013722. https:\/\/doi.org\/10.1002\/art.42382 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"78462_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1181928","volume":"327","author":"E Boilard","year":"2010","unstructured":"Boilard, E. et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 327, 580\u2013583. https:\/\/doi.org\/10.1126\/science.1181928 (2010).","journal-title":"Science"},{"key":"78462_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/BOR.0b013e3282eeb3a4","volume":"19","author":"AE Postlethwaite","year":"2007","unstructured":"Postlethwaite, A. E. & Chiang, T. M. Platelet contributions to the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol. 19, 574\u2013579. https:\/\/doi.org\/10.1097\/BOR.0b013e3282eeb3a4 (2007).","journal-title":"Curr. Opin. Rheumatol."},{"key":"78462_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gut.36.3.411","volume":"36","author":"GM Sch\u00fcrmann","year":"1995","unstructured":"Sch\u00fcrmann, G. M. et al. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut. 36, 411\u2013418. https:\/\/doi.org\/10.1136\/gut.36.3.411 (1995).","journal-title":"Gut"},{"key":"78462_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4149\/bll_2014_018","volume":"115","author":"Y Tekelioglu","year":"2014","unstructured":"Tekelioglu, Y., Uzun, H. & Sisman, G. Activated platelets in patients suffering from inflammatory bowel disease. Bratisl Lek Listy. 115, 83\u201385. https:\/\/doi.org\/10.4149\/bll_2014_018 (2014).","journal-title":"Bratisl Lek Listy"},{"key":"78462_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1182\/blood.V80.1.134.134","volume":"80","author":"LG de Bruijne-Admiraal","year":"1992","unstructured":"de Bruijne-Admiraal, L. G., Modderman, P. W., Von dem Borne, A. E. & Sonnenberg, A. P-selectin mediates ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood. 80, 134\u2013142 (1992).","journal-title":"Blood"},{"key":"78462_CR31","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1182\/blood-2013-05-468694","volume":"122","author":"M Gawaz","year":"2013","unstructured":"Gawaz, M. & Vogel, S. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood. 122, 2550\u20132554. https:\/\/doi.org\/10.1182\/blood-2013-05-468694 (2013).","journal-title":"Blood"},{"key":"78462_CR32","doi-asserted-by":"publisher","unstructured":"Pethaperumal, S., Hung, S. C., Lien, T. S., Sun, D. S. & Chang, H. H. P-Selectin is a critical factor for platelet-mediated Protection on Restraint stress-Induced Gastrointestinal Injury in mice. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms231911909 (2022).","DOI":"10.3390\/ijms231911909"},{"key":"78462_CR33","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1097\/HJH.0000000000002508","volume":"38","author":"L Zanoli","year":"2020","unstructured":"Zanoli, L. et al. Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular structure and function and the ARTERY Society. J. Hypertens. 38, 1682\u20131698. https:\/\/doi.org\/10.1097\/HJH.0000000000002508 (2020).","journal-title":"J. Hypertens."},{"key":"78462_CR34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1055\/s-0040-1709524","volume":"120","author":"Y Roka-Moiia","year":"2020","unstructured":"Roka-Moiia, Y. et al. Platelet activation via shear stress exposure induces a differing pattern of biomarkers of activation versus biochemical agonists. Thromb. Haemost. 120, 776\u2013792. https:\/\/doi.org\/10.1055\/s-0040-1709524 (2020).","journal-title":"Thromb. Haemost"},{"key":"78462_CR35","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3389\/fimmu.2019.01633","volume":"10","author":"TT Le","year":"2019","unstructured":"Le, T. T. et al. Purinergic Signaling in Pulmonary inflammation. Front. Immunol. 10, 1633. https:\/\/doi.org\/10.3389\/fimmu.2019.01633 (2019).","journal-title":"Front. Immunol."},{"key":"78462_CR36","doi-asserted-by":"publisher","first-page":"e1750","DOI":"10.1038\/cddis.2015.114","volume":"6","author":"SY Oh","year":"2015","unstructured":"Oh, S. Y., Lee, S. J., Jung, Y. H., Lee, H. J. & Han, H. J. Arachidonic acid promotes skin wound healing through induction of human MSC migration by MT3-MMP-mediated fibronectin degradation. Cell. Death Dis. 6, e1750. https:\/\/doi.org\/10.1038\/cddis.2015.114 (2015).","journal-title":"Cell. Death Dis."},{"key":"78462_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang, B. et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal. Transduct. Target. Ther. 6, 94. https:\/\/doi.org\/10.1038\/s41392-020-00443-w (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"78462_CR38","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41467-019-11140-w","volume":"10","author":"JP Motta","year":"2019","unstructured":"Motta, J. P. et al. Active thrombin produced by the intestinal epithelium controls mucosal biofilms. Nat. Commun. 10, 3224. https:\/\/doi.org\/10.1038\/s41467-019-11140-w (2019).","journal-title":"Nat. Commun."},{"key":"78462_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jso.26908","volume":"126","author":"JPA Da Silva","year":"2022","unstructured":"Da Silva, J. P. A. et al. Evaluation of platelet activation marker expression and its correlation with tumorigenesis and tumor progression in patients with gastric cancer. J. Surg. Oncol. 126, 125\u2013131. https:\/\/doi.org\/10.1002\/jso.26908 (2022).","journal-title":"J. Surg. Oncol."},{"key":"78462_CR40","doi-asserted-by":"publisher","first-page":"960398","DOI":"10.3389\/fcvm.2023.960398","volume":"10","author":"CC Rolling","year":"2023","unstructured":"Rolling, C. C., Barrett, T. J. & Berger, J. S. Platelet-monocyte aggregates: molecular mediators of thromboinflammation. Front. Cardiovasc. Med. 10, 960398. https:\/\/doi.org\/10.3389\/fcvm.2023.960398 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"78462_CR41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ajh.20655","volume":"81","author":"GE Pamuk","year":"2006","unstructured":"Pamuk, G. E. et al. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am. J. Hematol. 81, 753\u2013759. https:\/\/doi.org\/10.1002\/ajh.20655 (2006).","journal-title":"Am. J. Hematol."},{"key":"78462_CR42","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ibd\/izx106","volume":"24","author":"C Zamora","year":"2018","unstructured":"Zamora, C. et al. Inverse Association between Circulating Monocyte-Platelet Complexes and inflammation in Ulcerative Colitis patients. Inflamm. Bowel Dis. 24, 818\u2013828. https:\/\/doi.org\/10.1093\/ibd\/izx106 (2018).","journal-title":"Inflamm. Bowel Dis."},{"key":"78462_CR43","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.celrep.2019.06.062","volume":"28","author":"A Carestia","year":"2019","unstructured":"Carestia, A. et al. Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice. Cell. Rep. 28, 896\u2013908e895. https:\/\/doi.org\/10.1016\/j.celrep.2019.06.062 (2019).","journal-title":"Cell. Rep."},{"key":"78462_CR44","doi-asserted-by":"publisher","first-page":"611133","DOI":"10.3389\/fimmu.2020.611133","volume":"11","author":"SJ Lee","year":"2020","unstructured":"Lee, S. J. et al. Activated platelets convert CD14\u2009+\u2009CD16- into CD14\u2009+\u2009CD16\u2009+\u2009monocytes with enhanced Fc\u03b3R-Mediated phagocytosis and skewed M2 polarization. Front. Immunol. 11, 611133. https:\/\/doi.org\/10.3389\/fimmu.2020.611133 (2020).","journal-title":"Front. Immunol."},{"key":"78462_CR45","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/blood.2020007252","volume":"136","author":"ED Hottz","year":"2020","unstructured":"Hottz, E. D. et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 136, 1330\u20131341. https:\/\/doi.org\/10.1182\/blood.2020007252 (2020).","journal-title":"Blood"},{"key":"78462_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2017","unstructured":"Ataga, K. I. et al. Crizanlizumab for the Prevention of Pain crises in Sickle Cell Disease. N Engl. J. Med. 376, 429\u2013439. https:\/\/doi.org\/10.1056\/NEJMoa1611770 (2017).","journal-title":"N Engl. J. Med."},{"key":"78462_CR47","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1182\/bloodadvances.2022008209","volume":"7","author":"J Kanter","year":"2023","unstructured":"Kanter, J. et al. Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease. Blood Adv. 7, 943\u2013952. https:\/\/doi.org\/10.1182\/bloodadvances.2022008209 (2023).","journal-title":"Blood Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78462-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:05:07Z","timestamp":1731585907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78462-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78462"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78462-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4451346\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28055"}}